Illumina (ILMN) stock

Genetic sequencing tools , market cap $44B

Tools and services to analyze genetic material

Market cap $44B

$226.58

-3.99%

After-hours $226.58 0.00%

As of 5:14 PM ET after-hours, delayed 15+ min · Live for Pro members

Why is ILMN down?

Down 4.0% today with life science tool stocks: 14 of 15 are down, 5.3% on average; the S&P 500 is down 0.5%.

Fell on Oct 30

Down 19% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and life science tool stocks a median 6%.

It reported quarterly revenue of $1.13B and diluted EPS of $1.43 after the close on Oct 29.

Sources: Price history, Oct 30, 2026; SEC filing, Oct 29, 2026

−1Insider trades Keith A. Meister (Director) sold $1.6M on Sep 4 near the 52-week high, $436.2M in three months

Tell me next time ILMN moves

Free account, no card. An optional alert when ILMN moves or its score changes.

Or see it live, free until Wednesday morning. No account.

1 more reason, free with an account →1 more reason why ILMN fell on Oct 30, from its filings, with the other side, the timeline, and its peers, for Pro members.

Quality Score

Average

In its industry

#6of 15

Life Science Tools

Checks firing

0of 14

Trending up

From 52-week high

-26.8%

Above the 200-day

ILMN's Quality Score fell 1 point on Mon, Nov 2, to 9.

See ILMN's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on ILMN

Key facts on ILMN
Since its 2022 high	Down 44% while profit grew 8%
Latest filing	8-K, Oct 29 Reported its quarterly results

1 more reason behind ILMN's 9, free with an account →4 more reasons behind ILMN's 9, for Pro members.

ILMN in the news

TodayWith its group.

What's next

Tue Nov 10: UBS Global Healthcare Conference 2026Investor conference · date confirmed.

1 more date ahead: the conference, for Pro members.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

ILMN catalysts

Coming up

After its last 4 reports it closed -5.5% on average, higher 1 of 4 times.

42 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on ILMN and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Nothing is firing on ILMN right now

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on ILMN, and all 14 on every stock.Get in free →

ILMN RSI today: 35.9, below its 50-day, above its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1435.9
Above 30, below 50.
MACD (12, 26, 9)Below signal
Crossed below its signal line 1 session ago.
50-day average$249.44
The price is 9.2% below it.
200-day average$176.51
The price is 28.4% above it.
50/200 crossGolden cross
The 50-day crossed above the 200-day on Sep 29, 2025.
ADX 1435.0
25 or more, with +DI below -DI.
Support$200.01
Swing low from Sep 11, 11.7% below the price.
Resistance$231.81
Swing high from Aug 27, 2.3% above the price.
52-week high$309.35
From Oct 6, 36.5% above the price.
52-week low$106.12
From Oct 31, 2025, 53.2% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Below
The bands run from $239.55 to $298.28.
Volume1.2x
Against its 20-day average, for the time of day.

The deep dive on ILMN

What it does and how it makes money5 findingsServices made up 15% of its revenue in fiscal 2025 ($634M of $4.34B), against 16% in fiscal 2024; product sales 85%.SEC filing · Feb 12, 2026"As of December 28, 2025, we owned or had exclusive licenses to 1,380 issued U.S. patents and 1,120 pending U.S. patent applications and 7,653 issued patents outside the U.S. and 4,218 pending patent applications outside the U.S. Our issued and pending patents cover various aspects of our arrays, assays …" (10-K for fiscal 2025)SEC filing · Feb 12, 2026
Where it stands4 findingsFor Pro members4 findings on where ILMN stands: its cash, debt, and share count, for Pro members
What changed in its filings4 findings"On July 28, 2026, the Company filed a writ with the California Court of Appeals seeking interlocutory appellate review of the court’s order granting class certification." (10-Q for the quarter to Jun 28, 2026)SEC filing · Jul 31, 2026Backlog rose 16% in a year, to $1.00B on Jun 28, 2026 from $862M: sales under contract, not yet delivered.Filed figures, Jun 28, 2026
Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades ILMN, for Pro members
Against its closest peers4 peersShare count against a year before: ILMN -3.8%, WAT +65%, TXG +5%, A -0.7%.

13 more findings on ILMN, each with its source, for Pro membersGet in free →

How ILMN ranks in Life Science Tools

ILMN is #6 of 15 by Quality Score among Laboratory Analytical Instruments.

How ILMN ranks in Life Science Tools
1	MTDMettler-⁠Toledo International	7/14	16
2	AAgilent	4/14	15
3	WATWaters	5/14	13
	BRKRBruker		Open for its score
	CTKBCytek Biosciences		Open for its score
	MASS908 Devices		Open for its score
6	ILMNIllumina	0/14	9

Share count against a year before: ILMN -3.8%, WAT +65%, TXG +5%, A -0.7%.

When does ILMN report earnings, and what happens after?

Expected to report Thu Feb 4, after the close (in 94 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What ILMN reported on Oct 29, 2026

The quarter

Sales of $1.1B, 4% more than a year ago; a profit of $1.43 a share, from $0.98.

The quarter that ended Sep 27, from the company's press release

The press release The filing on EDGAR

Where the sales came from

ILMN's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
Measure	Figure
Fiscal year 2026
Total revenue	$4.64B to $4.66Braised

Figures as filed (SEC filing, Oct 29)

4 more outlook lines, for Pro members.

The numbers

Market value: $44B; today
Sales: $4.5B; up 4.9% on the year
Free cash flow: $931M; last 12 months

Sales grew 6% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 1.1% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on ILMN: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →

+7.1%0.0%-18.6%

Apr 30Jul 30Oct 29

Reported	When	Gap	Reaction	5 sessions
Oct 29, 2026After close	After close	-11.8%	-18.6%	open
Jul 30, 2026After close	After close	-0.9%	0.0%	-5.5%
Apr 30, 2026After close	After close	+5.1%	+7.1%	+9.4%

ILMN closed higher after 1 of its last 4 reports.

All 4 reports, and ILMN's Quality Score going into each

ILMN sales and profit by year

Sales and profit by year

Sales grew in three of the last seven years, to $4.3B in 2025. It turned a profit in 2025 after a loss in 2024.

Insiders trading ILMN

ILMN insider trades

One insider sold $591M across 93 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellKeith A. Meister$22MDirectorat $218.39 on Sep 4, filed Sep 4

SellKeith A. MeisterDirector$22Mat $218.39 on Sep 4, filed Sep 4

All 93 insider filings on ILMN from the last six months, for Pro members.Get in free →

All ILMN insider trades

ILMN trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

BuyDonald Trump$1K to $15KPresident (R)traded Apr 15, disclosed Jul 1(77 days later)

BuyDonald TrumpPresident (R)$1K to $15Ktraded Apr 15, disclosed Jul 1(77 days later)

All 2 trades on ILMN disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

ILMN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Jacob ThaysenChief Executive Officer
Ankur DhingraSVP, Chief Financial Officer
Scott M. DaviesChief Legal Officer · 4 trades
Christensen Jakob WedelSVP, Strategy/Corp Development · 3 trades
Patricia LeckmanSVP, Chief People Officer · 3 trades
Scott D. EricksenVP, Chief Accounting Officer · 2 trades
Julie Ann ColettiChief Legal Officer
Kevin Carl PegelsChief of Global Operations

11 more officers and directors file at ILMN. Each page above names the rest.

See insider trades by person

Which ETFs hold ILMN?

In ETFs: ILMN is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Illumina

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

8,650 employeesSan Diego, CAillumina.com

ILMN's score card

Illumina (ILMN): Quality Score 9, Average, #6 of 15 in Life Science Tools, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would move ILMN's score: 5 things
3 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayJul 1Donald Trump bought ILMN$1K to $15K, disclosed Jul 1

Alerts are optional.

See ILMN's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: ILMN's Quality Score is 9 (Average), #6 of 15 in Laboratory Analytical Instruments. Insiders sold $591M in the last 6 months (Form 4).

Is ILMN a good stock to buy? What its Quality Score says

ILMN scores 9 today, which Breakaway calls Average. It is #6 of 15 in Laboratory Analytical Instruments by Quality Score, with 0 of 14 chart checks firing. Down 19% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and life science tool stocks a median 6%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is ILMN's Quality Score?

ILMN scores 9 today, which Breakaway calls Average (6 to 10). That is #6 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ILMN's 9.

Are insiders buying ILMN?

One insider sold $591M across 93 filings in the last 6 months. No open-⁠market buys on record. The newest is Keith A. Meister, Director, who sold $22M on Sep 4. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.